Altimmune (FRA:3G0) Cyclically Adjusted FCF per Share: €-9.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3G0 Altimmune Inc FRA:3G0
28 GF Score
Price €2.52
! 2 Warning Signs
View Full Analysis

What is Altimmune Cyclically Adjusted FCF per Share?

Altimmune FRA:3G0 +3.49% 28 Cyclically Adjusted FCF per Share is €-9.74 as of Mar. 2026. GuruFocus rates FRA:3G0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Altimmune's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.146. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-9.74 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 19.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 15.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 31.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Altimmune was 58.60% per year. The lowest was 11.50% per year. And the median was 26.05% per year.

As of today (2026-07-28), Altimmune's current stock price is €2.52. Altimmune's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-9.74. Altimmune's Cyclically Adjusted Price-to-FCF of today is .


Altimmune  (FRA:3G0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Altimmune Cyclically Adjusted FCF per Share Related Terms


Altimmune Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Altimmune's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altimmune Cyclically Adjusted FCF per Share Chart

Altimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.83 -21.57 -18.59 -14.59 -10.55

Altimmune Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.26 -12.39 -11.72 -10.55 -9.74

FRA:3G0 vs VSTM, PRME, RLMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Altimmune's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Altimmune Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Altimmune's Cyclically Adjusted Price-to-FCF falls into.


FRA:3G0
28GF Score
Altimmune Inc FRA:3G0
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Altimmune Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Altimmune's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.146/330.2130*330.2130
=-0.146

Current CPI (Mar. 2026) = 330.2130.

Altimmune Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -6.470 241.018 -8.864
201609 -7.796 241.428 -10.663
201612 -6.322 241.432 -8.647
201703 -13.762 243.801 -18.640
201706 -17.154 244.955 -23.125
201709 -6.934 246.819 -9.277
201712 -7.194 246.524 -9.636
201803 -5.062 249.554 -6.698
201806 0.158 251.989 0.207
201809 -0.773 252.439 -1.011
201812 -0.500 251.233 -0.657
201903 -0.197 254.202 -0.256
201906 -0.207 256.143 -0.267
201909 -0.150 256.759 -0.193
201912 -0.120 256.974 -0.154
202003 -0.263 258.115 -0.336
202006 -0.360 257.797 -0.461
202009 -0.246 260.280 -0.312
202012 -0.303 260.474 -0.384
202103 -0.515 264.877 -0.642
202106 -0.536 271.696 -0.651
202109 -0.368 274.310 -0.443
202112 -0.460 278.802 -0.545
202203 -0.280 287.504 -0.322
202206 -0.333 296.311 -0.371
202209 -0.310 296.808 -0.345
202212 -0.327 296.797 -0.364
202303 -0.363 301.836 -0.397
202306 -0.353 305.109 -0.382
202309 -0.358 307.789 -0.384
202312 -0.259 306.746 -0.279
202403 -0.213 312.332 -0.225
202406 -0.237 314.175 -0.249
202409 -0.344 315.301 -0.360
202412 -0.245 315.605 -0.256
202503 -0.206 319.799 -0.213
202506 -0.206 322.561 -0.211
202509 -0.113 324.800 -0.115
202512 -0.157 324.054 -0.160
202603 -0.146 330.213 -0.146

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-9.74 mean?
Altimmune (FRA:3G0) has a Cyclically Adjusted FCF per Share of €-9.74 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Altimmune and its competitors.
Is Altimmune's Cyclically Adjusted FCF per Share too high?
Altimmune's current Cyclically Adjusted FCF per Share is €-9.74. Overall, Altimmune has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Altimmune's Cyclically Adjusted FCF per Share compare to VSTM and PRME?
Altimmune's Cyclically Adjusted FCF per Share of €-9.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Altimmune and its competitors. Altimmune's current Cyclically Adjusted FCF per Share is €-9.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altimmune stock overvalued right now?
Altimmune (FRA:3G0) has a current Cyclically Adjusted FCF per Share of €-9.74. The current Cyclically Adjusted FCF per Share is €-9.74. Altimmune's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Altimmune (FRA:3G0), the current Cyclically Adjusted FCF per Share is €-9.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altimmune Business Description

Address 910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
28GF Score

Get the complete analysis for FRA:3G0

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52
Price